MedPath

Fiber Longer Term Study on Energy Intake

Not Applicable
Completed
Conditions
Healthy
Interventions
Dietary Supplement: LM pectin (10%)
Dietary Supplement: gelatin
Registration Number
NCT01526759
Lead Sponsor
Wageningen University
Brief Summary

Dietary fibre seems to have a relevant role in body weight management. In an acute study the investigators found that high viscous-high gelling pectin increased feelings of satiety. The objective of this study is to study the effects of 2 weeks of supplementation of high gelling-high viscous fibre or a high gelling-high viscous non-fibre control on energy intake.

The investigators do this by measuring the difference in ad libitum energy intake after 15 days of pectin or 15 days of control supplements. The investigators will further measure differences in 24h feelings of satiety, fasting blood glucose and insulin, fermentation and composition of microbiota.

Detailed Description

Not available

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
35
Inclusion Criteria
  • Age: 18-30 year
  • BMI: 18.5-25 kg/m2
  • Healthy: as judged by the participant
  • H2 producer
Exclusion Criteria
  • Weight loss or weight gain of more than 5 kg during the last 2 months
  • Using an energy restricted diet during the last 2 months
  • Lack of appetite for any reason
  • Restrained eater
  • Smoking
  • Heavy alcohol use: >5 drinks/day
  • Reported stomach or bowel diseases or disorders (e.g. irritable bowel syndrome)
  • Reported diabetes
  • Reported thyroid disease or any other endocrine disorder
  • Using medication other than birth control, paracetamol, aspirin, hey fever and asthma
  • Antibiotic use <2 months before the study
  • Reported intolerance, allergy, or not liking of the research foods
  • Vegetarian
  • Current dietary fibre supplementation
  • Fasting glucose levels >5.8 mmol/l
  • Experienced any problems with drawing blood in the past
  • Thesis students or employees of the division of Human Nutrition
  • Volunteers who participated in the ProVe study

Study & Design

Study Type
INTERVENTIONAL
Study Design
CROSSOVER
Arm && Interventions
GroupInterventionDescription
pectinLM pectin (10%)10 gram high gelling-high viscous fiber, added to a drink
controlgelatin10g gelatin, added to a drink
Primary Outcome Measures
NameTimeMethod
Energy intakechange from placebo after 2 weeks

after 14 days of both intervention and placebo supplements ad libitum energy intake is measured for 3 days in a row. The change in energy intake will be calculated.

Secondary Outcome Measures
NameTimeMethod
satietychange from placebo after 1 day and 15 days

at day 1 and after 15 days of both supplement and placebo intake satiety is measured hourly over 1 day at waking hours. The change in satiety will be calculated.

fasting glucosechange from placebo after day 0, 1 and 15

at day 0, 1 and day 15 of supplementation period fasting glucose is measured

fasting insulinchange from placebo after day 0, 1 and 15

at day 0, 1 and day 15 of supplementation period fasting insulin is measured

fasting leptinchange from placebo after day 0, 1 and 15

at day 0, 1 and day 15 of supplementation period fasting leptin is measured

hydrogen in breathchange from placebo after day 2 and 15

at day 2 and at day 15 hydrogen is measured hourly over 1 day at waking hours

energy intakechange from placebo after day 0 and 1

before supplement intake and after 1 day of supplement 1-day ad libitum energy intake is measured. The change in energy intake will be calculated.

body weightchange from placebo after day 0,1,2,14,15, 16 and 17

Each day the subject reports to the research center, body weight is measured. The change in body weight compared to placebo will be calculated.

adverse eventsdaily from day 0 to day 16

participants will be asked to register adverse events daily in a diary. They are also asked to report ae's to the researchers. number and type of AEs after fibre supplements will be compared to number and type of AEs after placebo supplements

Trial Locations

Locations (1)

Wageningen University

🇳🇱

Wageningen, Netherlands

© Copyright 2025. All Rights Reserved by MedPath